Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
90.70
Dollar change
-0.19
Percentage change
-0.21
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y21.25% Shs Outstand Perf Week1.35%
SponsorVan Eck Associates Corporation ETF Type Tagsequity Return% 3Y11.99% Total Holdings27 Perf Month1.42%
Fund Family Bond Type Tagshealthcare Return% 5Y10.47% AUM534.58M Perf Quarter11.80%
IndexMVIS US Listed Pharmaceutical 25 Index Average Maturity Tagspharmaceutical Return% 10Y NAV% Perf Half Y13.33%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year18.45%
Active/Passive Quant Type Tags- Flows% 1M2.65% 52W Range74.05 - 91.00 Perf YTD11.47%
Dividend TTM1.70 (1.87%) ESG Type Tags- Flows% 3M8.27% 52W High-0.33% Beta0.65
Dividend Ex-DateDec 27, 2023 Dividend Type Sector/Theme Flows% YTD6.52% 52W Low22.48% ATR (14)0.74
Expense0.36% Structure Type Region Flows% 1Y RSI (14)63.24 Volatility0.60% 0.77%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.69 Prev Close90.89
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume130.33K Price90.70
SMA200.96% SMA502.97% SMA20010.85% Trades Volume89,722 Change-0.21%
Sep-20-22 03:13PM
Mar-26-22 10:00PM
Jan-24-22 01:38PM
Dec-14-21 10:38PM
May-22-20 07:46AM
10:03AM Loading…
May-18-20 10:03AM
Apr-09-20 10:10AM
Feb-07-20 11:05AM
Jan-22-20 01:00PM
Dec-20-19 08:10AM
Dec-05-19 03:34PM
Nov-22-19 05:15PM
Nov-08-19 08:00AM
Nov-06-19 11:00AM
Sep-30-19 06:04PM
11:27AM Loading…
Sep-23-19 11:27AM
Sep-09-19 02:09PM
Aug-22-19 11:12AM
Aug-07-19 10:59AM
Jun-28-19 06:01PM
Jun-26-19 11:00AM
Jun-25-19 06:01PM
May-14-19 05:40PM
May-09-19 10:05AM
Apr-30-19 12:59PM
Mar-29-19 06:42PM
Mar-21-19 07:56AM
Feb-21-19 10:08AM
Feb-07-19 11:15AM
Jan-29-19 09:08AM
09:27AM Loading…
Jan-07-19 09:27AM
Dec-26-18 06:37PM
Dec-14-18 09:28AM
Dec-10-18 10:33AM
Nov-16-18 05:52PM
Oct-24-18 11:59AM
Oct-17-18 11:48AM
Oct-12-18 06:00AM
Oct-09-18 11:39AM
Sep-28-18 06:03PM
Jul-03-18 03:19PM
Jun-29-18 06:15PM
Jun-04-18 10:38AM
Apr-24-18 06:41AM
Mar-29-18 05:58PM
Jan-25-18 09:00AM
07:31AM
Jan-22-18 10:00AM
07:34AM
Jan-15-18 10:31AM
Jan-10-18 12:03PM
Jan-09-18 10:31AM
Jan-08-18 07:33AM
Jan-05-18 10:35AM
Dec-26-17 06:15PM
Nov-22-17 05:30PM
Nov-14-17 02:35PM
Oct-16-17 12:33PM
Oct-02-17 12:35PM
Sep-29-17 05:25PM
Sep-20-17 10:36AM
Sep-19-17 10:38AM
Sep-14-17 07:39AM
Sep-11-17 10:36AM
07:36AM
Sep-06-17 09:06AM
Sep-05-17 07:37AM
Sep-04-17 09:06AM
Aug-31-17 12:34PM
07:38AM
Aug-30-17 07:36AM
Aug-23-17 11:53AM
09:53AM
Aug-21-17 04:05PM
Aug-17-17 07:37AM
Aug-15-17 09:06AM
Aug-14-17 10:25AM
Aug-07-17 09:53AM
Aug-01-17 11:21AM
07:41AM
Jul-31-17 06:05PM
Jul-28-17 05:05PM
Jul-27-17 07:44AM
Jul-25-17 04:25PM
Jul-24-17 01:05PM
10:37AM
Jul-17-17 10:39AM
10:27AM
Jul-11-17 09:07AM
Jul-10-17 03:10PM
07:39AM
Jul-04-17 10:37AM
07:36AM
Jul-03-17 09:10AM
Jun-30-17 05:27PM
Jun-28-17 10:36AM
Jun-21-17 09:08AM
Jun-20-17 12:09PM
Jun-08-17 09:06AM
Jun-02-17 07:36AM
VanEck Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.